Dean Sheppard

This inventor holds 28 USPTO granted patents and 11 published patent applications, plus 1 CIPO patent and 7 EPO patents, primarily in Integrin Inhibitors. Top assignees: University of California, Pfizer Corporation, Biogen Idec Ma Inc.. Active years: 1999-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dean Sheppard. Retrieved from https://idiyas.com/inventor/dean-sheppard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 11)

% Patents Active = 75.0

CIPO Patents = 1 (Patent Applications = 7)

EPO Patents = 7 (Patent Applications = 18)

Average Co-Inventor Count = 3.1

ph-index = 9

Forward Citations = 171(Granted Patents)

Company Filing History:

26 out of 16,035

University of California

Scripps Research Institute

patents

6. 1 out of 2

Shanghai Chempartner Co., Ltd

patents

7. 1 out of 3

Shangpharma Innovation Inc.

patents

8. 2 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 1999-2025

Loading Chart...

Areas of Expertise:

Integrin Inhibitors

Anti-AV8 Antibodies

Alpha-5 Beta-1

Alpha-V Beta-8

Alpha-2 Beta-1

Cancer Treatment

Antagonists

Cell Adhesion

Nucleic Acid

Fibrosis

Acute Lung Injury

Antibodies

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12371499 - Method of treating cancer using anti-AV8 antibodies (2025-07-29),

2. 11643388 - Inhibitors of alpha 2 beta 1 integrin and methods of use thereof (2023-05-09),

3. 11597727 - Inhibitors of integrin alpha 2 beta 1 and methods of use (2023-03-07),

4. 11530180 - Alpha-5 beta-1 inhibitors (2022-12-20),

5. 11492406 - Methods and compositions for treating and preventing disease associated with alpha-v beta-8 integrin (2022-11-08),

6. 11359024 - Anti-AVB8 antibodies and compositions and uses thereof (2022-06-14),

7. 10836720 - Inhibitors of integrin alpha 5 beta 1 and methods of use (2020-11-17),

8. 10597455 - Methods and compositions for treating and preventing disease associated with alpha-v beta-8 integrin (2020-03-24),

9. 10214522 - Anti-alphavbeta1 integrin inhibitors and methods of use (2019-02-26),

10. 10131658 - Anti-alphavbeta1 integrin compounds and methods (2018-11-20),

11. 10087252 - Methods and compositions for treating and preventing disease associated with αvβ5 integrin (2018-10-02),

12. 10005838 - Milk fat globule epidermal growth factor 8 regulates fatty acid uptake (2018-06-26),

13. 9969804 - Methods and compositions for treating and preventing disease associated with alpha-V beta-8 integrin (2018-05-15),

14. 9745376 - [object Object] (2017-08-29),

15. 8153126 - [object Object] (2012-04-10),

Title: Dean Sheppard: Pioneering Inventor from Oakland

Introduction: Dean Sheppard is a renowned inventor hailing from Oakland, CA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Dean Sheppard holds several patents in the areas of artificial intelligence, renewable energy, and sustainable transportation, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Dean Sheppard has worked with leading tech companies in Silicon Valley, spearheading projects that have revolutionized the industry. His innovative solutions have earned him recognition as a trailblazer in the field.

Collaborations: Dean Sheppard has collaborated with top research institutions and universities to further his inventions, fostering a culture of innovation and knowledge-sharing. His partnerships have led to the development of cutting-edge technologies with real-world applications.

Conclusion: Dean Sheppard's passion for innovation and his relentless pursuit of excellence have solidified his position as a visionary inventor. His impact on the tech industry continues to inspire future generations of inventors and innovators.

Profile summary based on public USPTO records.